Life Sciences

Noah Medical makes revolutionary foray into lung cancer...

Despite a promising outlook in terms of development, Noah Medical and its Ceo Ji...

Latest data drop backs Medtronic’s MiniMed closed loop ...

Medtronic shared the results of its ADAPT study for the efficiency of its MiniMe...

Hype For Karuna’s Schizophrenia Drug Continues

After announcing another late-stage success, Karuna Therapeutics’ much-anticipat...

Social anxiety nasal spray paves the way to success for...

VistaGen Therapeutics has announced the successful completion of Phase 3 safety ...

Takeda’s Autoimmune Therapy Shows Effectiveness in Majo...

Takeda has revealed the information that prompted them to buy the TYK2 inhibitor...

Dupixent may become the first biologic treatment for CO...

Late-stage trial data suggests Sanofi and Regeneron’s Dupixent is on its way to ...

Sanofi Becomes the Latest Drug Maker to Announce Insuli...

Sanofi has announced that it will reduce the list price of its popular insulin m...

Robots Set to Take Over Elder Healthcare From Humans in...

As the number of individuals in need of care is growing rapidly and there will p...

Rett syndrome drug by Acadia approved by U.S. FDA

The U.S. Food and Drug Administration (FDA) has granted approval to Acadia Pharm...

Life Science Industry: An Overview of Its Impact , Type...

The Life Sciences Industry is an ever-growing industry that is responsible for t...

FDA approves first-ever at-home test for both COVID and...

The first over-the-counter, at-home test that can identify both COVID-19 and inf...

$370M bid by Olympus for the acquisition of Taewoong Me...

Olympus has made a $370M bid to acquire Taewoong Medical.  An updated plan was h...

Moderna skin cancer medication gets FDA approval

Moderna announced that U.S. authorities have approved its experimental personali...

Life Sciences Voice Top Five Newsletter- March 2023

This week we take a look at FDA’s approval for the first home test kit, how soci...

FDA considers clearance for neuromodulation device as T...

The FDA is considering granting de novo clearance for a device aimed at treating...

Bayer, J&J’s Xarelto Shown to Reduce Ischemia Risk For ...

Patients suffering from peripheral arterial disease (PAD) frequently require low...